• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fluconazole treatment of candidal infections caused by non-albicans Candida species.

作者信息

van 't Wout J W

机构信息

Department of Infectious Diseases, University Hospital Leiden, The Netherlands.

出版信息

Eur J Clin Microbiol Infect Dis. 1996 Mar;15(3):238-42. doi: 10.1007/BF01591361.

DOI:10.1007/BF01591361
PMID:8740860
Abstract

Fluconazole is an effective alternative to amphotericin B for the treatment of serious infections caused by Candida albicans. Through a literature survey of candidal infections caused by non-albicans Candida spp., 43 cases treated with fluconazole were found. The most common causative organisms were Candida parapsilosis (14 patients), Candida glabrata (12 patients), and Candida tropicalis (11 patients). The dose of fluconazole varied from 50 to 400 mg daily. The median duration of treatment was 21 days. Overall efficacy was 77%. The efficacy against the various species was 93% for Candida parapsilosis, 50% for Candida glabrata, and 82% for Candida tropicalis. In conclusion, fluconazole is effective against the most common non-albicans Candida spp., although higher doses may be required for infections caused by Candida glabrata. Infections caused by Candida krusei should not be treated with fluconazole.

摘要

相似文献

1
Fluconazole treatment of candidal infections caused by non-albicans Candida species.
Eur J Clin Microbiol Infect Dis. 1996 Mar;15(3):238-42. doi: 10.1007/BF01591361.
2
Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei.氟康唑与两性霉素B对热带念珠菌、光滑念珠菌和克柔念珠菌的体内活性比较。
Antimicrob Agents Chemother. 1989 Sep;33(9):1443-6. doi: 10.1128/AAC.33.9.1443.
3
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
4
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.引起真菌血症的非白色念珠菌属：致病性与抗真菌耐药性
J Hosp Infect. 2002 Apr;50(4):243-60. doi: 10.1053/jhin.2001.1151.
5
Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV patients with candidiasis.多种蜂蜜对从患有念珠菌病的艾滋病患者中分离出的耐氟康唑念珠菌的杀菌效果。
J Mycol Med. 2017 Jun;27(2):159-165. doi: 10.1016/j.mycmed.2017.01.004. Epub 2017 Jan 31.
6
Antifungal susceptibilities of Candida species isolated from urine culture.从尿液培养物中分离出的念珠菌属的抗真菌药敏性。
J Infect Chemother. 2016 Sep;22(9):629-32. doi: 10.1016/j.jiac.2016.06.012. Epub 2016 Jul 21.
7
[Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool].[从血液、血管导管、尿液和粪便中分离出的念珠菌种类及其药敏情况]
Kansenshogaku Zasshi. 2012 Mar;86(2 Suppl 4):15-20.
8
Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.中国引起侵袭性念珠菌病的光滑念珠菌种复合体、克柔念珠菌、近平滑念珠菌种复合体和热带念珠菌的抗真菌药敏性：3 年国家监测。
J Antimicrob Chemother. 2015 Mar;70(3):802-10. doi: 10.1093/jac/dku460. Epub 2014 Dec 3.
9
Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.马来西亚一家医疗中心白色念珠菌性和非白色念珠菌性念珠菌尿症的患病率。
J Pak Med Assoc. 2014 Dec;64(12):1375-9.
10
Current status and fluconazole treatment of pelvic fungal gynecological infections.盆腔真菌性妇科感染的现状及氟康唑治疗
Chemotherapy. 2000 May-Jun;46(3):209-12. doi: 10.1159/000007281.

引用本文的文献

1
Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection.艾滋病毒感染患者口咽念珠菌病和食管念珠菌病的优化管理。
HIV AIDS (Auckl). 2010;2:89-101. doi: 10.2147/hiv.s6660. Epub 2010 Apr 28.
2
Role of posaconazole in the management of oropharyngeal and esophageal candidiasis.泊沙康唑在口咽和食管念珠菌病治疗中的作用。
Ther Clin Risk Manag. 2007 Aug;3(4):533-42.
3
Successful treatment of fungus balls due to fluconazole-resistant Candida sake obstructing ureter stents in a renal transplant patient.

本文引用的文献

1
Treatment of Candida albicans fungaemia with fluconazole.
J Infect. 1993 Mar;26(2):133-46. doi: 10.1016/0163-4453(93)92761-k.
2
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.光滑念珠菌感染与中性粒细胞减少的骨髓移植患者氟康唑预防用药的相关性。
Antimicrob Agents Chemother. 1993 Sep;37(9):1847-9. doi: 10.1128/AAC.37.9.1847.
3
Fluconazole in the management of fungal ocular infections.
Ophthalmologica. 1994;208(3):147-56. doi: 10.1159/000310473.
4
Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):43-5. doi: 10.1007/s10096-005-0066-y.
4
Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.光滑念珠菌侵袭性分离株对七种全身用抗真菌药物敏感性的地域差异：2001年和2002年开展的ARTEMIS抗真菌监测项目的全球评估
J Clin Microbiol. 2004 Jul;42(7):3142-6. doi: 10.1128/JCM.42.7.3142-3146.2004.
5
Characterization of agglutinin-like sequence genes from non-albicans Candida and phylogenetic analysis of the ALS family.非白念珠菌凝集素样序列基因的特征分析及ALS家族的系统发育分析
Genetics. 2001 Apr;157(4):1555-67. doi: 10.1093/genetics/157.4.1555.
6
Secreted aspartic proteinase family of Candida tropicalis.热带假丝酵母分泌天冬氨酸蛋白酶家族
Infect Immun. 2001 Jan;69(1):405-12. doi: 10.1128/IAI.69.1.405-412.2001.
7
Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Fluconazole Global Susceptibility Study Group.致病性念珠菌属对氟康唑的敏感性评估。氟康唑全球敏感性研究组。
Eur J Clin Microbiol Infect Dis. 1997 Dec;16(12):924-8. doi: 10.1007/BF01700561.
8
When should Candida isolates be tested for susceptibility to azole antifungal agents?念珠菌分离株何时应进行唑类抗真菌药物敏感性测试？
Eur J Clin Microbiol Infect Dis. 1997 Apr;16(4):281-2. doi: 10.1007/BF01695631.
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.一项比较氟康唑与两性霉素B治疗非中性粒细胞减少患者念珠菌血症的随机试验。念珠菌血症研究组与国立研究所。
N Engl J Med. 1994 Nov 17;331(20):1325-30. doi: 10.1056/NEJM199411173312001.
5
Importance of Candida species other than C. albicans as pathogens in oncology patients.除白色念珠菌外的念珠菌属作为肿瘤患者病原体的重要性。
Clin Infect Dis. 1995 Jan;20(1):115-25. doi: 10.1093/clinids/20.1.115.
6
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.一项关于氟康唑与两性霉素B治疗非中性粒细胞减少念珠菌血症患者的随机多中心试验中分离菌株的抗真菌药敏试验。美国国立过敏和传染病研究所真菌病研究组及念珠菌血症研究组。
Antimicrob Agents Chemother. 1995 Jan;39(1):40-4. doi: 10.1128/AAC.39.1.40.
7
Fluconazole in the treatment of candidal prosthetic valve endocarditis.氟康唑治疗念珠菌性人工瓣膜心内膜炎。
BMJ. 1988 Jul 16;297(6642):178-9. doi: 10.1136/bmj.297.6642.178.
8
A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections.氟康唑（UK-49,858）治疗深部真菌感染疗效的前瞻性研究。
J Antimicrob Chemother. 1988 May;21(5):665-72. doi: 10.1093/jac/21.5.665.
9
Fluconazole treatment of Candida glabrata peritonitis.氟康唑治疗光滑念珠菌性腹膜炎。
J Antimicrob Chemother. 1989 Jul;24(1):94-6. doi: 10.1093/jac/24.1.94-a.
10
Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent.
Am J Med. 1989 Jun;86(6 Pt 2):825-7. doi: 10.1016/0002-9343(89)90481-6.